Tenax Therapeutics, Inc. SEC filings TENX

Tenax Therapeutics, Inc. has 995 filings in SEC EDGAR's recent list, going back to Aug 2, 1996. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
10-K Annual report Mar 10, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
10-K Annual report Mar 25, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2022 Dec 31, 2021
10-K/A Amended annual report Apr 16, 2021 Dec 31, 2020
10-K Annual report Mar 31, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
10-K Annual report Apr 1, 2019 Dec 31, 2018
10-K Annual report Apr 2, 2018 Dec 31, 2017
10-K Annual report Mar 16, 2017 Dec 31, 2016
10-KT Transition report Mar 14, 2016 Dec 31, 2015
10-K Annual report Jul 14, 2015 Apr 30, 2015
10-K Annual report Jul 29, 2014 Apr 30, 2014
10-K Annual report Jun 26, 2013 Apr 30, 2013
10-K Annual report Jul 25, 2012 Apr 30, 2012
10-K/A Amended annual report Aug 29, 2011 Apr 30, 2011
10-K Annual report Jul 15, 2011 Apr 30, 2011
ARS Annual report to shareholders Aug 25, 2010 Apr 30, 2010
10-K Annual report Jul 23, 2010 Apr 30, 2010
10-K/A Amended annual report Mar 25, 2010 Apr 30, 2009
10-K Annual report Aug 12, 2009 Apr 30, 2009
10-K Annual report Aug 13, 2008 Apr 30, 2008
10-K Annual report Aug 14, 2007 Apr 30, 2007
10-K Annual report Jul 28, 2006 Apr 30, 2006
10-K Annual report Aug 15, 2005 Apr 30, 2005
10-K Annual report Aug 13, 2004 Apr 30, 2004
10-K Annual report Jul 18, 2003 Apr 30, 2003
10-K Annual report Jul 26, 2002 Apr 30, 2002
10-K Annual report Jul 26, 2001 Apr 30, 2001

Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TENX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chapel Hill, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
34956
Former names
OXYGEN BIOTHERAPEUTICS, INC. (until Sep 15, 2014); SYNTHETIC BLOOD INTERNATIONAL INC (until Jun 30, 2008)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.